4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-052229
Chief Executive Officer sold 1,325 shares at $1.98 ($2,619)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-03 | Sale : show line 1 in the form 10b5-1 | −1,325 | $1.98 | $2,619 | 890,558 | D |
| Open-market sales · 1,325 sh · avg $1.98 · $2,619 | ||||||
Loading xslF345X05/doc4.xml…